Related Experiment Video

Updated: Aug 17, 2026

Identification of Kinesin-1 Cargos Using Fluorescence Microscopy
08:06

Identification of Kinesin-1 Cargos Using Fluorescence Microscopy

Published on: February 14, 2016

Inhibitors of kinesin motor proteins--research and clinical progress

David M Duhl1, Paul A Renhowe

  • 1Chiron Corporation, 4560 Horton Street, Emeryville, CA 94608, USA.

Current Opinion in Drug Discovery & Development
|July 19, 2005
PubMed

Insights

New cancer drugs targeting microtubule stability show promise. This review highlights advances in developing kinesin spindle protein (Eg5) inhibitors as a potentially less toxic alternative to current antimitotic therapies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Drug Discovery

Background:

  • Microtubule-targeting agents are crucial in cancer therapy but cause significant toxicities like neurotoxicity and neutropenia.
  • Acquired resistance, often via P-glycoprotein pumps, limits the efficacy of existing antimitotic drugs.
  • There is a critical need for novel antimitotic agents with improved safety profiles and different mechanisms of action.

Purpose of the Study:

  • To review recent advancements in the design and development of kinesin motor protein inhibitors.
  • To focus on small-molecule, non-ATP-competitive inhibitors targeting kinesin spindle protein (Eg5).
  • To explore new therapeutic avenues for less toxic cancer treatments.

Main Methods:

  • Literature review of recent research (last year) on kinesin motor protein inhibitors.
  • Focus on small-molecule inhibitors specifically targeting Eg5.
  • Analysis of non-ATP-competitive inhibition mechanisms.

Main Results:

  • Significant progress has been made in the development of Eg5 inhibitors.
  • Non-ATP-competitive inhibitors represent a promising class of antimitotic agents.
  • These inhibitors offer a potential alternative to overcome resistance mechanisms.

Conclusions:

  • Kinesin spindle protein (Eg5) inhibitors are a promising area for developing novel cancer therapeutics.
  • Targeting Eg5 may offer a strategy for less toxic and more effective cancer treatment.
  • Continued research into these agents could lead to improved oncolytic therapies.

More Related Videos

Isolation and Purification of Kinesin from Drosophila Embryos09:49

Isolation and Purification of Kinesin from Drosophila Embryos

Published on: April 27, 2012

Single-Molecule Analysis of Sf9 Purified Superprocessive Kinesin-3 Family Motors08:16

Single-Molecule Analysis of Sf9 Purified Superprocessive Kinesin-3 Family Motors

Published on: July 27, 2022

Related Concept Videos

The Movement of Organelles and Vesicles01:43

The Movement of Organelles and Vesicles

In eukaryotic cells,  cytoskeletal filaments such as actin, microtubules, and intermediate filaments form a mesh-like cytoskeletal network. These filaments serve as tracks for transporting cellular cargo. Specialized motor proteins use the chemical energy stored in adenosine triphosphate (ATP) for this transport. During interphase, microtubules are polarized, with the plus-end towards the cell periphery and the minus-end towards the cell center. Two microtubule-associated motor proteins,...
Destabilization of Microtubules01:45

Destabilization of Microtubules

The destabilization of microtubules can occur during different stages of the microtubule lifecycle, such as nucleation or elongation. It can take place at either end of the microtubule or in the microtubule lattices as a whole. The lifespan of individual microtubules within a cell varies according to the cell type and stage of the cell cycle. During interphase, the lifespan of the microtubule is about 30 minutes, while during cell division, it is about 15 minutes. In axonal microtubules of...
Microtubule Associated Motor Proteins01:32

Microtubule Associated Motor Proteins

Eukaryotic cells have different motor proteins for transporting various cargo within the cell. These motor proteins differ based on the filament they associate with, the direction they move within the cell, and the type of cargo they transport. Motor proteins that associate with microtubules are known as microtubule-associated motor proteins. There are two families of microtubule-associated motor proteins —Kinesins and Dyneins. Both these proteins assist in the transport of cellular cargos...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
ATP Synthase: Mechanism01:48

ATP Synthase: Mechanism

In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased ATP...